@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R27F64FN-H skos:prefLabel "Thiophènes"@fr, "Thiophenes"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-NXWWV8XK-T . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-HRXVCQ2Z-Q skos:prefLabel "Analgesics"@en, "Analgésiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NXWWV8XK-T mesh:pharmacologicalAction jvr:-HRXVCQ2Z-Q, jvr:-F3DML4KH-4, jvr:-RKGZF8PT-H, jvr:-CW1BZZWB-6 ; owl:sameAs ; mesh:allowableQualifier jvr:-TJHVZCRZ-0, jvr:-HQRFT0C6-B, jvr:-W6SQV79N-S, jvr:-NHL3D2X0-S, jvr:-R3QWLHRG-V, jvr:-L6C0XPHT-4, jvr:-R0ZCQ8X6-J, jvr:-FWD2BGQ0-9, jvr:-NB0XHT3S-N, jvr:-NFTHND7Q-8, jvr:-CB30NGKB-3, jvr:-G4R176S9-J, jvr:-H7K65Q8S-Z, jvr:-S0CS1X5R-5, jvr:-Q3979798-W, jvr:-BT300B3G-Q, jvr:-THHNVC7V-3, jvr:-XV06LPML-W, jvr:-M63HSDM7-1, jvr:-G30ZJ446-J, jvr:-T9HQD7ST-J, jvr:-WK5F724J-1, jvr:-SBNWSM1T-R, jvr:-D0F21513-5, jvr:-NKM836P1-M ; skos:hiddenLabel "LY-248686"@fr, "LY-248686"@en, "N-methyl-3-(1-naphthalenyloxy)-2-thiophenepropanamine"@en, "Duloxetine Ethanedioate (1:1), (+-)-isomer - T353987"@en, "N-methyl-3-(1-naphthalenyloxy)-3-(2-thiophene)propanamide"@en, "Duloxetine, (+)-isomer"@en, "LY 227942"@en, "Cymbalta"@en, "LY227942"@fr, "LY227942"@en, "Duloxetine"@en, "LY-227942"@fr, "LY-227942"@en, "Duloxétine"@fr, "LY248686"@fr, "LY 248686"@en ; skos:altLabel "Duloxetine HCl"@en, "136434-34-9 (Duloxetine Hydrochloride)"@fr, "136434-34-9 (Duloxetine Hydrochloride)"@en, "9044SC542W"@en, "9044SC542W"@fr, "118625-29-9"@fr, "118625-29-9"@en, "116539-58-3"@en, "116539-58-3"@fr, "O5TNM5N07U"@fr, "O5TNM5N07U"@en, "116539-59-4"@fr, "116539-59-4"@en, "116539-60-7"@fr, "116539-60-7"@en ; skos:definition "A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA."@en ; skos:inScheme jvr: ; a mesh:Descriptor, skos:Concept ; skos:prefLabel "Chlorhydrate de duloxétine"@fr, "Duloxetine Hydrochloride"@en ; skos:broader jvr:-R27F64FN-H ; dc:created "2015-07-09"^^xsd:date ; dc:modified "2016-05-31"^^xsd:date ; dc:established "2016-01-01"^^xsd:date . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CW1BZZWB-6 skos:prefLabel "Agents dopaminergiques"@fr, "Dopamine Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-RKGZF8PT-H skos:prefLabel "Antidépresseurs"@fr, "Antidepressive Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-F3DML4KH-4 skos:prefLabel "Serotonin and Noradrenaline Reuptake Inhibitors"@en, "Inhibiteurs de la recapture de la sérotonine et de la noradrénaline"@fr ; a mesh:Descriptor, skos:Concept .